Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review
The aim of this work was to assess the association between graft-to-recipient weight ratio (GRWR) in adult-to-adult living donor liver transplantation (LDLT) and hepatocellular carcinoma (HCC) recurrence. A search of the MEDLINE and EMBASE databases was performed until December 2022 for studies comp...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/7/6224 |
_version_ | 1797607920969449472 |
---|---|
author | Alessandro Parente Hwui-Dong Cho Ki-Hun Kim Andrea Schlegel |
author_facet | Alessandro Parente Hwui-Dong Cho Ki-Hun Kim Andrea Schlegel |
author_sort | Alessandro Parente |
collection | DOAJ |
description | The aim of this work was to assess the association between graft-to-recipient weight ratio (GRWR) in adult-to-adult living donor liver transplantation (LDLT) and hepatocellular carcinoma (HCC) recurrence. A search of the MEDLINE and EMBASE databases was performed until December 2022 for studies comparing different GRWRs in the prognosis of HCC recipients in LDLT. Data were pooled to evaluate 1- and 3-year survival rates. We identified three studies, including a total of 782 patients (168 GRWR < 0.8 vs. 614 GRWR ≥ 0.8%). The pooled overall survival was 85% and 77% at one year and 90% and 83% at three years for GRWR < 0.8 and GRWR ≥ 0.8, respectively. The largest series found that, in patients within Milan criteria, the GRWR was not associated with lower oncological outcomes. However, patients with HCC outside the Milan criteria with a GRWR < 0.8% had lower survival and higher tumor recurrence rates. The GRWR < 0.8% appears to be associated with lower survival rates in HCC recipients, particularly for candidates with tumors outside established HCC criteria. Although the data are scarce, the results of this study suggest that considering the individual GRWR not only as risk factor for small-for-size-syndrome but also as contributor to HCC recurrence in patients undergoing LDLT would be beneficial. Novel perfusion technologies and pharmacological interventions may contribute to improving outcomes. |
first_indexed | 2024-03-11T05:36:21Z |
format | Article |
id | doaj.art-eed108a9961a4f7a8e0a57f35a028dda |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-11T05:36:21Z |
publishDate | 2023-03-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-eed108a9961a4f7a8e0a57f35a028dda2023-11-17T16:48:10ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-03-01247622410.3390/ijms24076224Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic ReviewAlessandro Parente0Hwui-Dong Cho1Ki-Hun Kim2Andrea Schlegel3HPB and Transplant Unit, Department of Surgical Science, University of Rome Tor Vergata, 00133 Rome, ItalyDivision of Hepatobiliary and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of KoreaDivision of Hepatobiliary and Liver Transplantation, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of KoreaFondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Centre of Preclinical Research, 20122 Milan, ItalyThe aim of this work was to assess the association between graft-to-recipient weight ratio (GRWR) in adult-to-adult living donor liver transplantation (LDLT) and hepatocellular carcinoma (HCC) recurrence. A search of the MEDLINE and EMBASE databases was performed until December 2022 for studies comparing different GRWRs in the prognosis of HCC recipients in LDLT. Data were pooled to evaluate 1- and 3-year survival rates. We identified three studies, including a total of 782 patients (168 GRWR < 0.8 vs. 614 GRWR ≥ 0.8%). The pooled overall survival was 85% and 77% at one year and 90% and 83% at three years for GRWR < 0.8 and GRWR ≥ 0.8, respectively. The largest series found that, in patients within Milan criteria, the GRWR was not associated with lower oncological outcomes. However, patients with HCC outside the Milan criteria with a GRWR < 0.8% had lower survival and higher tumor recurrence rates. The GRWR < 0.8% appears to be associated with lower survival rates in HCC recipients, particularly for candidates with tumors outside established HCC criteria. Although the data are scarce, the results of this study suggest that considering the individual GRWR not only as risk factor for small-for-size-syndrome but also as contributor to HCC recurrence in patients undergoing LDLT would be beneficial. Novel perfusion technologies and pharmacological interventions may contribute to improving outcomes.https://www.mdpi.com/1422-0067/24/7/6224living donor liver transplantationhepatocellular carcinomagraft-to-recipient weight ratiograft sizetumor recurrence |
spellingShingle | Alessandro Parente Hwui-Dong Cho Ki-Hun Kim Andrea Schlegel Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review International Journal of Molecular Sciences living donor liver transplantation hepatocellular carcinoma graft-to-recipient weight ratio graft size tumor recurrence |
title | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review |
title_full | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review |
title_fullStr | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review |
title_full_unstemmed | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review |
title_short | Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review |
title_sort | association between hepatocellular carcinoma recurrence and graft size in living donor liver transplantation a systematic review |
topic | living donor liver transplantation hepatocellular carcinoma graft-to-recipient weight ratio graft size tumor recurrence |
url | https://www.mdpi.com/1422-0067/24/7/6224 |
work_keys_str_mv | AT alessandroparente associationbetweenhepatocellularcarcinomarecurrenceandgraftsizeinlivingdonorlivertransplantationasystematicreview AT hwuidongcho associationbetweenhepatocellularcarcinomarecurrenceandgraftsizeinlivingdonorlivertransplantationasystematicreview AT kihunkim associationbetweenhepatocellularcarcinomarecurrenceandgraftsizeinlivingdonorlivertransplantationasystematicreview AT andreaschlegel associationbetweenhepatocellularcarcinomarecurrenceandgraftsizeinlivingdonorlivertransplantationasystematicreview |